Q3 2023 Holdings
Filed 2023-11-14 | 26 holdings | $347.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $70.5M | 5,160,975 | 20.3% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $69.7M | 4,408,379 | 20.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $20.6M | 438,442 | 5.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $20.1M | 1,472,264 | 5.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $17.9M | 313,210 | 5.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $13.7M | 462,286 | 4.0% |
| VOR Biopharma Inc | COM | 929033108 | $13.5M | 6,361,723 | 3.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $12.3M | 587,600 | 3.5% |
| Rallybio Corp | COM | 75120L100 | $12.2M | 3,630,724 | 3.5% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $9.8M | 490,000 | 2.8% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $8.5M | 1,200,647 | 2.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $8.5M | 310,270 | 2.5% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $8.4M | 192,500 | 2.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.7M | 790,440 | 2.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $6.5M | 585,000 | 1.9% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $6.4M | 357,733 | 1.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $6.3M | 410,000 | 1.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $6.3M | 320,000 | 1.8% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $5.7M | 411,450 | 1.6% |
| Spruce Biosciences Inc | COM | 85209E109 | $5.3M | 2,364,000 | 1.5% |
| Homology Medicines Inc | COM | 438083107 | $5.3M | 4,535,919 | 1.5% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $4.2M | 665,555 | 1.2% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $4.1M | 404,404 | 1.2% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.7M | 1,305,000 | 0.5% |
| Impel Pharmaceuticals Inc | COM | 45258K109 | $1.2M | 2,884,791 | 0.4% |
| Cidara Therapeutics Inc | COM | 171757107 | $1.1M | 1,134,511 | 0.3% |